Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

REACH

3-aminopropan-1-ol

EC number: 205-864-4 | CAS number: 156-87-6

Life Cycle description
Uses advised against

Toxicological information

Toxicological Summary

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure

Hazard assessment conclusion:: low hazard (no threshold derived)

Acute/short term exposure

Hazard assessment conclusion:: low hazard (no threshold derived)

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:: DNEL (Derived No Effect Level)
Value:: 3.3 mg/m³
Most sensitive endpoint:: repeated dose toxicity

DNEL related information

Overall assessment factor (AF):: 3
Dose descriptor:: NOAEC

Acute/short term exposure

Hazard assessment conclusion:: low hazard (no threshold derived)
Most sensitive endpoint:: skin irritation/corrosion

DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure

Hazard assessment conclusion:: DNEL (Derived No Effect Level)
Value:: 1 mg/kg bw/day
Most sensitive endpoint:: repeated dose toxicity

DNEL related information

Overall assessment factor (AF):: 120

Acute/short term exposure

Hazard assessment conclusion:: low hazard (no threshold derived)

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:: medium hazard (no threshold derived)
Most sensitive endpoint:: skin irritation/corrosion

Acute/short term exposure

Hazard assessment conclusion:: medium hazard (no threshold derived)
Most sensitive endpoint:: skin irritation/corrosion

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:: medium hazard (no threshold derived)

Additional information - workers

Long-term – inhalation, local/systemic effects (based on the 28 days inhalation study in rats)

Description	Value	Remark
Step 1) Relevant dose-descriptor	NOAEC: 10 mg/m³	The exposure of rats to Monoethanolamine caused concentration-related lesions in larynx, trachea and lung. No histopathological effects were seen in any other organ outside the respiratory tract. The NOAEC for local effect was the lowest tested concentration of 10 mg/m³under the current test conditions. The NOAEC for systemic toxicity is the highest concentration of 150 mg/m³.
Step 2) Modification of starting point	1	According to the REACH guidance, time scaling is not appropriate when the toxic effect is mainly driven by the exposure concentration; Correction for activity is not neccesary becaues the effect is mainly driven by a local mechanism and the corrosive properties of the substance on the larynx and on the trachea. Due to the fact that the rat is an obligatory nose breather the teat-species is in this case over-predictive.No modification of the starting point is applied.
Modified dose-descriptor	10 mg/m³
Step 3) Assessment factors
Interspecies	1	No factor for allometric scaling is needed in case of inhalation exposure.Furthermore, the factor for remaining uncertainties is not needed as the rat is a more sensitive species for inhalation exposure and an obligatory nose breather.
Intraspecies	3	Using a reduced factor of 3 is justified because the critical effect is a local effect that is hardly, if at all, determined by toxicodynamics and kinetics. Absorption, distribution and elimination play no/a minor role. Local effects are largely concentration-dependent whereas exposure time and enzyme polymorphisms are of minor importance in such cases. Due to the fact that the local effects are driven by local exposure peaks and are not supposed to worsen with time and considering the rat is over-predictive in this case, a joint assessment factor of 3 is applied for intraspecies differences and exposure duration correction.
Exposure duration	3
Dose response	1
Quality of database	1
DNEL	Value
	10 / (1 x 3 x 1 x 1) =3.3 mg/m³

Long-term – dermal, systemic effects (based on the 28 days inhalation study in rats)

Using the inhalation study as starting point, the following DNEL is derived:

Description	Value	Remark
Step 1) Relevant dose-descriptor	NOAEC: 150 mg/m³	No systemic effects were observed after inhalation exposure up to 150 mg/m³for 28 days.
Step 2) Modification of starting point	0.29 100/37.5	A 6 h respiratory volume of 0.29 m³/kg bw for rats was used for conversion into NOAEL upon dermal exposure. Correction for absorption: 100% absorption upon inhalation exposure; 37.5% absorption is assumed for dermal exposure.
Modified dose-descriptor	150 x 0.29 x (100/37.5) = 116 mg/kg bw/day
Step 3) Assessment factors
Interspecies	4 x 1	Assessment factor for allometric scaling. As no effects were observed up to the highest concentration tested, the factor for remaining uncertainties is not applied.
Intraspecies	5	Default assessment factor
Exposure duration	6	The key study is a 28 days inhalation study.
Dose response	1
Quality of database	1
DNEL	Value
	116 / (4 x 1 x 5 x 6 x 1 x 1) = 1 mg/kg bw/day (Taking the dermal NOAEL for maternal toxicity (systemic effects) from the developmental toxicity study with rats (Liberacki et al, 1996) as starting point, i.e., 75 mg/kg bw/day, a DNEL of 1.5 mg/kg bw/day (75 / (4 x 2.5 x 5 x 1 x 1) = 1.5 mg/kg bw/day) is calculated)

It has to be noted that this is a conservative approach.

General Population - Hazard via inhalation route

Systemic effects

Long term exposure

Hazard assessment conclusion:: no hazard identified

Acute/short term exposure

Hazard assessment conclusion:: no hazard identified

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:: no hazard identified

Acute/short term exposure

Hazard assessment conclusion:: no hazard identified

DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure

Hazard assessment conclusion:: no hazard identified

Acute/short term exposure

Hazard assessment conclusion:: no hazard identified

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:: no hazard identified

Acute/short term exposure

Hazard assessment conclusion:: no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure

Hazard assessment conclusion:: no hazard identified

Acute/short term exposure

Hazard assessment conclusion:: no hazard identified

DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:: no hazard identified

Additional information - General Population

Since 3 -Aminopropan-1-ol is used at industrial and professional domains only, no exposure of the general population is expected. Therefore, no DNELs for the general population were calculated.

Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.